(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 29, 2021 2:00 PM - Dec 01, 2021 7:00 PM

(Central Europe Standard Time)

Clinical Trial Disclosure & Data Transparency Conference

Evolving Requirements and New Challenges

Back to Agenda

Session 2: UK Disclosure Requirements Updates'

Session Chair(s)

Scott Feiner

Scott Feiner

Senior Manager, Trial Disclosure

AbbVie, United States

In recent months, the United Kingdom’s disclosure requirements post-Brexit have come into greater focus.

This session provides updates from the HRA on their disclosure requirements, and a sponsor perspective on using the latest guidance documents to meet the clinical trial disclosure requirements of the UK.

Speaker(s)

Naho Yamazaki, PhD

Expanding Disclosure Requirements From the HRA

Naho Yamazaki, PhD

Health Research Authority, United Kingdom

Deputy Director, Policy and Partnerships

Joyce Swart

Example of Interventional, Non-Interventional and Device Trials A Sponsor Walkthrough of UK Clinical Trial Disclosure Guidance

Joyce Swart

Alcon Research, LLC, United States

Clinical Disclosure Lead

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.